Live Breaking News & Updates on Greg Landes

Press release content from Business Wire. The AP news staff was not involved in its creation.
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments
February 10, 2021 GMT
BigHat co-founders Mark DePristo and Peyton Greenside (Photo: Business Wire)
SAN CARLOS, Calif. (BUSINESS WIRE) Feb 10, 2021
BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today announced it has raised $19 million in an oversubscribed Series A funding round, led by Andreessen Horowitz, with participation from prior investors 8VC, AME Cloud Ventures and Innovation Endeavors. As part of the investment, Andreessen Horowitz General Partner, Vineeta Agarwala, MD, PhD joins BigHat’s Board of Directors. ....

United States , United Kingdom , San Carlos , Jake Gardner , Stan Lapidus , Kerry Walker , Vineeta Agarwala , Liz Schwarzbach , Bighat Biosciences , Brian Kobilka , Andreessen Horowitz , Andrew Gordon Wilson , Theresa Tribble , Mark Depristo , Greg Landes , Francisco Gimenez , Small Business Innovation Research , Founding Team , University Of Cambridge , National Institute Of Standards , Walker Communications , Harvard University , University Of Pennsylvania , Antibody Development , Hat Biosciences , Andreessen Horowitz General Partner ,